Tapewire

NYSE · USD

LLY

ELI LILLY & Co

Export transactions ↓
Tapewire entity
2794
SEC CIK
0000059478
Parsed reports
2,757

Last 12 months

Inside the activity.

0 purchase rows · 240 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250200
Dec 202503
Jan 2026031
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 19, 2023 Filed May 22, 2023 16:01 UTC SaleCommon Stock 163,571 $442.30 $72,347,944.01
Disclosure

SEC source: 0001209191-23-031356 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,504,593

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $442.00 to $442.96, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:21 UTC GrantCommon Stock 26 $434.51 $11,297.26
Disclosure

SEC source: 0000059478-23-000170 · wf-form4_168426847189268.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,051

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:23 UTC GrantCommon Stock 23 $434.51 $9,993.73
Disclosure

SEC source: 0000059478-23-000172 · wf-form4_168426856870058.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,972

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:24 UTC GrantCommon Stock 23 $434.51 $9,993.73
Disclosure

SEC source: 0000059478-23-000174 · wf-form4_168426865232884.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:26 UTC GrantCommon Stock 22 $434.51 $9,559.22
Disclosure

SEC source: 0000059478-23-000176 · wf-form4_168426878118857.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,094

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:28 UTC GrantCommon Stock 33 $434.51 $14,338.83
Disclosure

SEC source: 0000059478-23-000178 · wf-form4_168426886823912.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,951

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:29 UTC GrantCommon Stock 11 $434.51 $4,779.61
Disclosure

SEC source: 0000059478-23-000180 · wf-form4_168426897503157.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,659

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:31 UTC
Zakrowski Donald ASVP, Finance, & CAO
SaleCommon Stock 600 $435.29 $261,174.00
Disclosure

SEC source: 0000059478-23-000182 · wf-form4_168426907790371.xml · nonDerivative · entry 1

Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,978

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2022.

Read SEC document
May 12, 2023 Filed May 15, 2023 17:01 UTC SaleCommon Stock 2,602 $444.40 $1,156,331.40
Disclosure

SEC source: 0001209191-23-029303 · doc4.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,668,164

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $444.1445 to $444.78, inclusive.

Read SEC document
May 12, 2023 Filed May 15, 2023 17:01 UTC SaleCommon Stock 5,359 $443.22 $2,375,226.70
Disclosure

SEC source: 0001209191-23-029303 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,670,766

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $443.01 to $443.63, inclusive.

Read SEC document
May 12, 2023 Filed May 15, 2023 17:01 UTC SaleCommon Stock 12,685 $442.25 $5,609,877.83
Disclosure

SEC source: 0001209191-23-029303 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,676,125

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $442.00 to $442.70, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 1,500 $433.56 $650,341.50
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 18

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,688,810

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $433.29 to $434.00, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 7,866 $432.73 $3,403,838.45
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 17

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,690,310

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $432.26 to $433.20, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 13,507 $431.86 $5,833,078.99
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 16

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,698,176

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $431.25 to $432.24, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 30,817 $430.73 $13,273,652.33
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 15

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,711,683

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $430.25 to $431.2425, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 17,648 $429.72 $7,583,698.56
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 14

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,742,500

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $429.245 to $430.23, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 14,500 $428.69 $6,216,034.00
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 13

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,760,148

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.245 to $429.23, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 6,050 $427.84 $2,588,438.05
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 12

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,774,648

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $427.245 to $428.24, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 1,900 $426.51 $810,361.40
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 11

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,780,698

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $426.16 to $426.86, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 4,147 $425.77 $1,765,668.19
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 10

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,782,598

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $425.16 to $426.15, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 6,248 $424.42 $2,651,801.15
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,786,745

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $424.115 to $425.06, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 12,829 $423.69 $5,435,454.87
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,792,993

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $423.11 to $424.105, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 19,630 $422.66 $8,296,855.06
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,805,822

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $422.11 to $423.10, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 19,684 $421.65 $8,299,758.60
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,825,452

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.105 to $422.10, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 9,226 $420.60 $3,880,492.50
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,845,136

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $420.105 to $421.10, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 6,400 $419.77 $2,686,528.00
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,854,362

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $419.08 to $420.065, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 3,200 $418.55 $1,339,353.60
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,860,762

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $417.93 to $418.90, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 2,750 $417.13 $1,147,096.50
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,863,962

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $416.67 to $417.595, inclusive.

Read SEC document
May 03, 2023 Filed May 4, 2023 18:30 UTC SaleCommon Stock 400 $415.72 $166,286.00
Disclosure

SEC source: 0001209191-23-027283 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,866,712

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.425 to $416.065, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), and (18) to this Form 4.

Read SEC document
May 02, 2023 Filed May 3, 2023 19:13 UTC SaleCommon Stock 13,832 $410.56 $5,678,879.75
Disclosure

SEC source: 0001209191-23-026907 · doc4.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,867,112

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $410.16 to $411.055, inclusive.

Read SEC document
May 02, 2023 Filed May 3, 2023 19:13 UTC SaleCommon Stock 17,513 $409.71 $7,175,233.72
Disclosure

SEC source: 0001209191-23-026907 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,880,944

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.13 to $410.105, inclusive.

Read SEC document
May 02, 2023 Filed May 3, 2023 19:13 UTC SaleCommon Stock 10,353 $408.72 $4,231,478.16
Disclosure

SEC source: 0001209191-23-026907 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,898,457

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $408.11 to $409.10, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 5,915 $403.77 $2,388,281.81
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,908,810

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.27 to $404.235, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 11,765 $402.58 $4,736,306.64
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,914,725

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.24 to $403.205, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 32,167 $401.68 $12,920,969.23
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,926,490

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.24 to $402.235, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 8,803 $400.76 $3,527,855.07
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,958,657

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.19 to $401.185, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 13,899 $399.36 $5,550,662.94
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,967,460

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.02 to $399.98, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 30,820 $398.50 $12,281,739.18
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,981,359

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.02 to $399.01, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 38,118 $397.56 $15,154,306.43
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,012,179

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $397.02 to $398.01, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 64,998 $396.59 $25,777,426.82
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,050,297

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $396.02 to $397.01, inclusive.

Read SEC document
April 28, 2023 Filed May 1, 2023 18:32 UTC SaleCommon Stock 18,515 $395.36 $7,320,108.92
Disclosure

SEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,115,295

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $395.00 to $396.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), and (9) to this Form 4.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:26 UTC GrantCommon Stock 30 $372.35 $11,170.50
Disclosure

SEC source: 0000059478-23-000144 · wf-form4_168193599784567.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,025

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:28 UTC GrantCommon Stock 27 $372.35 $10,053.45
Disclosure

SEC source: 0000059478-23-000146 · wf-form4_168193607349396.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,949

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:29 UTC GrantCommon Stock 27 $372.35 $10,053.45
Disclosure

SEC source: 0000059478-23-000148 · wf-form4_168193613806276.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 930

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:30 UTC GrantCommon Stock 26 $372.35 $9,681.10
Disclosure

SEC source: 0000059478-23-000150 · wf-form4_168193620979651.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,072

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:31 UTC GrantCommon Stock 39 $372.35 $14,521.65
Disclosure

SEC source: 0000059478-23-000152 · wf-form4_168193630076058.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,918

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:33 UTC GrantCommon Stock 13 $372.35 $4,840.55
Disclosure

SEC source: 0000059478-23-000154 · wf-form4_168193637640401.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,648

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:34 UTC GrantCommon Stock 5 $372.35 $1,861.75
Disclosure

SEC source: 0000059478-23-000156 · wf-form4_168193646715773.xml · nonDerivative · entry 1

TAI JACKSON P · CIK 0001173275 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,524

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 06, 2023 Filed Apr 7, 2023 15:38 UTC SaleCommon Stock 915 $369.38 $337,978.13
Disclosure

SEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,133,810

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.275 to $369.435, inclusive.

Read SEC document
April 06, 2023 Filed Apr 7, 2023 15:38 UTC SaleCommon Stock 46,903 $368.63 $17,289,759.08
Disclosure

SEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,134,725

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.275 to $369.26, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.